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Abstract
The supply of calcium to the developing neonate via milk is an important physiological process. Until 
recently the mechanism for the enrichment of milk with calcium was thought to be almost entirely 
mediated via the secretory pathway. However, recent studies suggest that a specific isoform of the plasma 
membrane calcium ATPase, PMCA2, is the primary mechanism for calcium transport into milk, 
highlighting a major role for apical calcium transport. We compared the expression of the recently 
identified secretory calcium ATPase, SPCA2, and SPCA1, in the mouse mammary gland during different 
stages of development. SPCA2 levels increased over 35 fold during lactation, while SPCA1 increased 
only a modest two fold. The potential importance of SPCA2 in lactation was also highlighted by its
localization to luminal secretory cells of the mammary gland during lactation, while SPCA1 was
expressed throughout the cells of the mammary gland. We also observed major differences in the 
localization of PMCA2 and PMCA1 during lactation. Using the SCp2 mouse mammary epithelial cell 3D 
culture model, differences in the sub-cellular distribution of PMCA2 and PMCA1 were clear. These 
studies highlight the likely specific roles of PMCA2 and SPCA2 in lactation, and link the recently 
characterized SPCA2 calcium pump to the supply of calcium into milk and the regulation of Golgi 
resident enzymes important in lactation.  They also indicate that calcium transport into milk is a complex 
interplay between apical and secretory pathways.  
Keywords (3 to 5 words that do not appear in the title)
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Introduction
Intracellular free Ca2+ levels are under tight regulation and control, with resting free cytosolic Ca2+ levels
maintained at around 100 nM (3). The amplitude, location, duration and frequency of intracellular Ca2+
increases (sometimes into the µM range) regulate a variety of cellular processes including gene 
transcription, proliferation and cell death (3). This regulation is achieved by proteins responsible for the 
translocation of Ca2+ ions, which include Ca2+ channels, Ca2+ exchangers and Ca2+ pumps (3, 4). During 
lactation, the unidirectional transport of Ca2+ from the maternal blood supply to the milk must be achieved 
without causing major disturbances to cellular signaling within the epithelial cells of the mammary gland
(11). Concurrent with tightly maintaining intracellular Ca2+ levels, a large gradient between free and total 
Ca2+ between the maternal blood supply and milk is established. Indeed the total Ca2+ content of blood is 
3 mM (11), while that of the milk is approximately 8 mM in humans, and over 60 mM in other species 
such as mice (13). 
Active transporters of Ca2+ ions include the plasma membrane Ca2+ ATPases (PMCAs), the sarcoplasmic 
endoplasmic Ca2+-ATPases (SERCAs) and the secretory pathway Ca2+-ATPases (SPCAs) (4, 11). 
Consistent with a minor role for the endoplasmic reticulum in Ca2+ enrichment of milk, levels of SERCA
isoform transcripts expressed in the rat mammary gland (SERCA2 and SERCA3) do not significantly 
increase during pregnancy or during the early stages of lactation (18). In contrast, PMCA2, which has a 
highly restricted tissue distribution (9, 22), increases approximately 30 fold during the early stages of 
lactation in the rat mammary gland as compared to the almost undetectable levels in nulliparous rats (17, 
18). The presence of PMCA2 protein in milk fat globule membranes suggests a predominately apical 
distribution for PMCA2 during lactation, and a major role in the efflux of Ca2+ across the apical 
membrane into milk (13, 17). The reduction in the Ca2+ content of milk in PMCA2 null mice by 60%
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(19), when combined with only a comparatively modest increase (6-8 fold) in the expression of the 
secretory pathway pump SPCA1 (17, 18), challenges the widely cited view of little to no involvement of 
direct apical transport of Ca2+ and the major role of the Golgi apparatus during lactation (13). Although a 
possible role for PMCA2-mediated Ca2+ accumulation into the Golgi during trafficking to the membrane 
has been discussed (19), the recent report of PMCA2 localization to the apical membrane in mammary 
tissue from a lactating mouse (25) represents further evidence for its direct role in apical calcium 
transport.
The regulation of key Golgi enzymes involved in post-translational modification of milk proteins and 
lactose production by Ca2+ and Mn2+ (11, 12), both substrates for the secretory pathway Ca2+ pump (24), 
still suggests a major role for Golgi Ca2+ accumulation in lactation, as does the secretion of Ca2+ in casein 
micelles derived from the Golgi (13). In this study we sought to address the dichotomy arising from the 
modest increase in SPCA1 expression and the pronounced increase in PMCA2 during lactation, and the 
seemingly major role for the secretory pathway in Ca2+ secretion for the enrichment of milk with Ca2+
(13). 
Subsequent to the studies discussed above regarding the expression of SPCA1 and PMCA2 in lactation, a 
second secretory pathway Ca2+ / Mn2+ pump isoform has been identified, named SPCA2, encoded by the 
ATP2C2 gene in humans (27). Similar to PMCA2, SPCA2 has a more restricted tissue distribution 
compared to SPCA1. SPCA2 is expressed in the brain and testis (27) as well as the cells of 
gastrointestinal and respiratory tract and mammary, salivary, and thyroid glands (26). Differences in the 
enzyme properties of SPCA1 and SPCA2, such as the higher catalytic turnover rate for Ca2+ of SPCA2 
compared with SPCA1, when over-expressed in HEK-293 cells, are proposed as possible evidence for
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specific functional roles for SPCA2, particularly in secretory cells (7). However, the possible 
physiological processes where SPCA2 may play a major role are still unclear. In these studies, we 
addressed the hypothesis that SPCA2 expression undergoes greater changes in expression than SPCA1 
during pregnancy and lactation, and that PMCA isoforms and SPCAs have unique cellular distributions 
during lactation consistent with specific roles in Ca2+ homeostasis in the mammary gland and the 
transport of Ca2+ into milk.
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Materials and Methods
Animals
Animal ethics approval was obtained for all studies from the University of Queensland animal ethics 
committee. CBA x C57Bl6 mice were fed standard rodent chow and water ad libitum. Nulliparous 
animals were euthanized at 14 weeks of age. For all other developmental stages, dams were mated when 
12 weeks old. Animals were then sacrificed at the following stages of mammary gland development: mid-
pregnancy (~ day 10); lactation (day 1); and involution (48h post-forced weaning). Pregnant animals were 
estimated to be day 10 based on microscopic examination of the developing fetus. The glands from 
lactating mice were imbedded in Optimum Cutting Temperature (OCT) compound (Tissue-Tek®, 
Torrance, CA) and frozen on dry ice for tissue sectioning. 
RNA isolation and Real Time RT-PCR
Total RNA was isolated from whole mammary glands using the Qiagen RNeasy mini Kit incorporating 
an on-column DNase treatment (Qiagen, Doncaster, Vic, Australia). RNA was quantified
spectrophotometrically at 260 nm. All samples were stored at -80 ˚C until required. SPCA1 and SPCA2 
mRNA levels were quantified using real time RT-PCR. The mRNA was reverse transcribed using the 
Omniscript® RT kit (Qiagen) while the real time PCR step was performed using a TaqMan® universal 
PCR master mix (Applied Biosystems, Scoresby, VIC, Australia) and the following TaqMan® gene 
expression assays: Mm00723486_m1 (SPCA1; Applied Biosystems); and Mm01242899_m1 (SPCA2; 
Applied Biosystems). Expression was normalized to endogenous 18S rRNA levels and is expressed 
relative to nulliparous animals. Reactions were cycled in an ABI PRISM 7500 Sequence Detector 
(Applied Biosystems) under the following conditions: 95 ˚C for 10 min; followed by 40 cycles of 95 ˚C 
for 15 s and 60 ˚C for 1 min. Threshold cycle (Ct) values were used for all analysis. Three separate PCR 
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reactions were performed from each RNA sample from each mouse, to assess variability in Ct responses 
between replicates and between mice. The mean differences between Ct responses for the different 
targets, and their standard errors, were estimated using a random effects model, with an additional mouse 
effect, allowing for the variation in Ct responses between and within mice. Standard errors of further 
quantities derived from these estimates were determined using the delta technique. Significance was 
assessed using a z-test based on a normal distribution.
Immunofluoresence (in vivo samples)
Glands were sectioned at 5 µM thickness.  Sections were fixed with 4 % paraformaldehyde (ProSciTech, 
Thuringowa Central, QLD, Australia) in phosphate buffered saline (PBS; Sigma Aldrich, Castle Hill, 
NSW, Australia). Slides were incubated with primary antibody for 1 h at room temperature in a 
humidified chamber. Primary antibodies used included: anti PMCA1 (1:100, PA1-914; Affinity 
BioReagents, Golden, CO); anti-PMCA2 (1:800, PA1-915; Affinity BioReagents); affinity purified anti-
SPCA1 (1:500); affinity purified anti-SPCA2 (1:100 (27)); and anti-smooth muscle actin (SMA) Cy3 
Conjugate (1:400, 1A4; Sigma Aldrich). Sections were incubated with the secondary antibody Alexa 
Fluor® - 488 goat anti-rabbit (1:500; Molecular Probes, Mt Waverley, VIC, Australia) for 40 min, at 
room temperature in a humidified chamber. Cells were co-stained with the nuclear stain 4,6-diamidino-2-
phenylindole (DAPI; 2 µg/mL; Sigma Aldrich). Fluorescence images were captured with a Nikon Eclipse 
TE300 microscope (Nikon UK, Kingston, UK), equipped with a 40X oil immersion NA 1.3 objective lens 
(Nikon), and with MetaFluor® imaging software (Universal Imaging, Downington, PA). DAPI, Alexa 
Fluor® 488, and Cy3 were excited at 364 nm, 488 nm and 540 nm, respectively, and emitted light was 
collected at 454 nm, 520 nm, and 570 nm, respectively. Exposure times for the three channels were 500 
ms, 1000 ms and 1000 ms, respectively. All images were analyzed with MetaMorph®, version 6.2 r5 
(Universal Imaging).  
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Cell culture
SCp2 cells, a clonal derivative of the COMMA 1D mouse mammary epithelial cell line (5) were routinely 
cultured in Dulbecco's modified Eagle's medium (DMEM)/Hams F-12 (UCSF Cell Culture Facility, San 
Francisco, CA) supplemented with 2% (v/v) fetal bovine serum (Atlanta Biologicals, Lawrenceville, GA), 
gentamicin (50 µg/mL, UCSF Cell Culture Facility) and insulin (5 µg/mL; Sigma-Aldrich) (6). Cultures 
were maintained at 37 ˚C in a humidified 5 % CO2/ 95 % air incubator. SCp2 were grown also as a three-
dimensional (3D) culture on top of a layer of reconstituted basement membrane gel from Engelbreth-
Holm-Swarm extracellular matrix extract, growth factor-reduced (Matrigel; BD Biosciences, Bedford, 
MA) (10). Briefly, wells of a 12 well plate (Falcon, Franklin Lakes, NJ) were coated with 80 µL of 
chilled Matrigel, rocked to ensure even coverage and incubated at 37 ˚C for approximately 40 min to 
allow the Matrigel to solidify. SCp2 cells were trypsinized as usual and seeded at a density of 7.6 x 104
cells/well on top of the solidified Matrigel and left to adhere for 1 h. Media were then replaced with 
differentiation media, which consisted of DMEM/F-12 supplemented with gentamicin (50 µg/mL), 
insulin (5 µg/mL), hydrocortisone (1 µg/mL; Sigma Aldrich), prolactin (3 µg/mL; Sigma Aldrich), and 2 
% Matrigel. All media were refreshed every 2-3 days with fresh differentiation media for 7 days. Cells 
were harvested by aspirating the culture media, and scraping the Matrigel/cell suspension from the bottom 
of the well. The Matrigel/cell suspension (15µL) was then smeared onto a microscope slide and allowed 
to dry for 10 – 15 min at room temperature. The slides were either stored at -20 ˚C until required or 
immunostained immediately.
Immunofluorescence (SCp2 cells)
Cells grown in a monolayer (2D) to approximately 90 % confluence in 8-well chamber slides (Nalge 
Nunc International, Rochester, NY), or in 3D, were fixed in an ice cold methanol/acetone solution (1/1; 
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v/v) for 10 min on ice. Slides were blocked for 1 h with IF wash buffer (0.1% BSA, 0.2% Triton X100, 
0.05% Tween 20 in PBS) plus 10 % goat serum (UCSF Cell Culture Facility) then incubated with 
primary antibody overnight at 4 ºC. Primary antibody dilutions were anti-PMCA1 (1:100), anti-PMCA2 
(1:300) and anti–6 integrin (1:100; MAB 1378; Chemicon International, Temecula, CA). Slides were 
incubated with the following secondary antibodies for 40 min at room temperature: goat anti-rat Alexa 
Fluor® 568 and goat anti-rabbit Alexa Fluor® 488 (all 1:500; Molecular Probes). Cells were co-stained 
with DAPI (2 µg/mL). Widefield fluorescence images were obtained with a Nikon Diaphot 300 
microscope equipped with a Nikon PlanApo 60X (NA 1.4) objective lens and Spot RT camera and 
software (Diagnostic Instruments Inc., Sterling Heights, MI).  Confocal analysis was performed using a 
Solamere Technology Group (Salt Lake City, UT) spinning disk confocal system comprised of a Zeiss 
Axiovert 200M inverted microscope, Yokagawa CSU10 confocal scan head and Stanford Photonics 
XR/Mega-10 ICCD camera, run by QED InVivo software (Media Cybernetics). Images were obtained 
using Zeiss LD Plan-Neofluar 40X (NA 0.6) and Zeiss Plan-Apochromat 63X (NA 1.4) objective lenses. 
Fluorochromes DAPI, Alexa Fluor® 488/FITC and Alexa Fluor® 568 were excited with 405 nm, 488 
nm, and 568 nm light, respectively, and emitted light was collected using the following emission filters: 
D460/50, HQ535/50 and HQ620/60 (Chroma Technology Corp., Rockingham, VT). Optical z-sections 
were acquired at 0.5 µm intervals and are an average of 4 exposures. Exposure times for the three 
channels were 400 ms, 200 ms, and 200 ms, respectively. All images were analyzed with MetaMorph®, 
version 6.2 r5.  
Immunoblotting
Total cell lysates were isolated from SCp2 cells grown in 2D monolayers on 12 well plates (in the 
presence of normal media or differentiation inducing media) to reach approximately 90 % confluence, 
using RIPA buffer (1% NP-40, 0.5 % sodium deoxycholate, 0.1% SDS, 150 mM NaCl, 50 mM Tris-HCl, 
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pH 7.4) plus 10 ul/mL protease inhibitor cocktail set 1 (Calbiochem®, San Diego, CA). Protein 
concentration was determined using Bio-Rad DC protein assay reagents (BioRad, Hercules, CA). Proteins
(30 µg) were resolved using a 10% tris-glycine SDS page gel (Invitrogen, Carlsbad, CA) then transferred 
to a nitrocellulose membrane. Membranes were incubated for 1 h at room temperature with primary 
antibodies. These included: anti -actin (1:1000, AC-15; Sigma Aldrich) and anti–-casein (1:1000)
prepared from a hybridoma kindly provided by Dr Kaetzel, Institute of Pathology, Case Western Reserve 
University, Cleveland, OH (23). Secondary antibodies goat anti-mouse or goat anti-rabbit IgG horseradish 
peroxidise-conjugated (both 1:1000; Pierce, Rockford, IL), were incubated for 40 min at room 
temperature. Proteins were visualized using the SuperSignal West Femto Maximum Sensitivity Substrate 
kit (Pierce) and a FluorChem™ 8900 Chemi Imager (Alpha Innotech Corp., San Leandro, CA).
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Results
To ascertain which isoform, SPCA1 or SPCA2, is the predominant isoform up-regulated during lactation, 
their mRNA levels were compared in mammary glands isolated from nulliparous, pregnant, lactating and 
involuting mice. Consistent with the increase seen in SPCA1 in rats (17, 18), mouse SPCA1 levels 
increased modestly during pregnancy (~ 1.5 fold at day 10) and lactation (~ 2 fold at day 1) (Fig 1). In 
contrast, a dramatic up-regulation of SPCA2 was observed in mouse mammary glands during lactation (~ 
35 fold at day 1) with an increase also seen during pregnancy (~ 8 fold at day 10) compared to nulliparous 
animals (Fig 1). 
Consistent with its more restricted tissue distribution (26), SPCA2 was expressed predominately in 
luminal epithelial cells of the mouse mammary gland during lactation (Fig 2A & B; compare with 
myoepithelial cells identified by smooth muscle actin staining), with no expression in cells outside the 
acini (arrows). The staining pattern was vesicular throughout the cell interior, consistent with localization 
to the secretory pathway. SPCA1 staining was also punctate, however, this isoform was expressed in all 
cell types of the tissue section, including myoepithelial and stromal cells (Fig 2C & D).  
Analogous to SPCA1 and SPCA2, PMCA1 and PMCA2 exhibited differential isoform expression in the 
different cell types of the mammary gland during lactation, with distinct differences in sub-cellular 
distribution. Fig 3A & B shows PMCA2 in the lactating mouse mammary gland. Consistent with its 
restricted distribution, PMCA2 expression appeared confined to the alveolus, whereas non-acinar cells did 
not express PMCA2. PMCA2 also exhibited an apical localization in many of the acinar structures. Such 
a distribution suggests that PMCA2 may have a role in the direct translocation of Ca2+ across the apical 
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membrane and is consistent with the recent work of VanHouten et al (25). In sharp contrast to PMCA2, 
PMCA1 appeared to be ubiquitously expressed in the mammary gland sections (Fig 3C & D) with a more 
basolateral distribution, consistent with a possible role in regulation of cytosolic free Ca2+ in cells of the 
mammary gland, rather than the active transport of Ca2+ into milk.
To confirm the distinct differences between PMCA1 and PMCA2 in sub-cellular distribution under more 
controlled conditions, the mouse mammary SCp2 cell line was differentiated to produce 3D acini (Fig 4A 
& B). These cells were polarized to form a lumen and secreted the milk protein, -casein (Fig 4C),
analogous to primary cultures (2). In this culture model, SPCA2 expression was vesicular in both 2D (Fig 
4D) and 3D (Fig 4E). PMCA1 and PMCA2 exhibited pronounced differences in their sub-cellular 
localization. PMCA1 expression was basolateral (Fig 5), whereas PMCA2 localization was more 
predominant towards the apical membrane and exhibited a cytosolic punctate staining (Fig 6). These 
studies shed some light on the distinct roles of these calcium pumps through their differential expression 
and localization, sub-cellularly as well as in different cell types, of the mammary gland.
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Discussion
The modest increase in SPCA1 expression compared with PMCA2 expression during lactation in the rat 
(17, 18), and the reduction of the Ca2+ content of milk in PMCA2-/- mice (19), has challenged the dogma 
of the greater importance of the Golgi compared to the apical membrane in the enrichment of milk with 
Ca2+. The data presented here suggest that SPCA2, rather than SPCA1, is the major secretory pathway 
Ca2+ ATPase important in lactation and is consistent with a major role of the Golgi in Ca2+ enrichment in 
milk.
The role of SPCA2 in mammary gland secretory cells during lactation is likely to be two-fold: Firstly, the 
up-regulation of SPCA2 may function to supply the secretory pathway with Ca2+ ions for packaging into 
casein micelles for calcium secretion into milk (13). Indeed, the higher enzymatic turnover rate of SPCA2 
compared to SPCA1 when over-expressed in HEK-293 cells and its high apparent affinity for Ca2+ (7),
suggests that SPCA2 has an enhanced capability to replenish Golgi Ca2+ as Ca2+ is lost via secretion (7). 
Since milk has a high Ca2+ content, lactation is an event where loss of Ca2+ from the tissue would be
pronounced, and our observation of increased levels of SPCA2 during lactation is suggestive that this 
SPCA isoform has a major role in meeting the demand for Golgi Ca2+ replenishment. The second role for 
SPCA2 in lactation may go beyond the supply of Ca2+ to the Golgi for secretion into milk, and relate to 
the control of Ca2+ and Mn2+ ions in the Golgi for the regulation of Golgi-localized Ca2+ and Mn2+
sensitive enzymes, which are critical for posttranslational modification of milk proteins and lactose 
production (11). 
One key enzyme for which the regulation of Ca2+ and Mn2+ may be important is 1,4--
galactosyltransferase I. This enzyme is a trans-Golgi enzyme (20) and is responsible for the transfer of 
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galactose, a key event in the formation of some glycoconjugates (8, 20). 1,4--Galactosyltransferase I is 
up-regulated during lactation, where it forms a heterodimer with -lactalbumin to enable lactose 
production for secretion into milk (20). The increase in both 1,4--galactosyltransferase I and SPCA2 
during mid-pregnancy (20), combined with the sensitivity of 1,4--galactosyltransferase I to Mn2+ (21)
suggests that SPCA2 may also be important in regulating the activity of this enzyme, and subsequently 
the lactose and glycoprotein profile of milk. The up-regulation of SPCA2 during mid-pregnancy is likely 
to be hormonally regulated as SPCA2 transcription is increased by prolactin in human MCF-7 breast 
cancer cells (1) and prolactin levels increase during pregnancy (14).
In addition to highlighting a physiological role for SPCA2 in lactation, this study provides further 
evidence for the isoform specific roles of PMCA2 and PMCA1 in the mammary gland, through the 
demonstration of their distinct sub-cellular and cellular locations during lactation. As expected, the 
ubiquitously expressed PMCA1 was present in the majority of cells in the lactating mammary gland with 
a basolateral localization both in vivo during lactation and in 3D culture. Such a distribution of PMCA1 is 
consistent with a role in the regulation of calcium fluxes in mammary gland epithelial cells, rather than 
direct transport of calcium into milk. Conversely, PMCA2 was localized to the secretory alveolus in vivo, 
with an apical localization, which is consistent with its proposed role in direct apical transportation of 
Ca2+ ions into milk (19, 25). PMCA2 localization in the 3D culture model appeared more pronounced 
towards the apical membrane, however, a vesicular distribution was also apparent, suggestive of a high 
turnover due to loss of PMCA2 during lactation as previous proposed (17), or indicative of a role for 
PMCA2 in the accumulation of Ca2+ into secretory vesicles (19) during particular periods of lactation. 
The reduction of total milk Ca2+ content by 60% in PMCA2 null mice, combined with the major 
contribution of casein micelles in milk Ca2+ enrichment, could also suggest a role for PMCA2 in Golgi
Ca2+ accumulation (19). However, the observation that PMCA2 heterozygous mice do not have reduced
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milk Ca2+ content, despite a 38% reduction in mammary PMCA2 levels (19), and our observation of 
pronounced up-regulation of SPCA2, suggests that more complex reasons may exist for the pronounced 
reduction of Ca2+ milk content in PMCA2 null mice, and that this result does not imply that 60% of Ca2+
transport into milk is mediated via PMCA2. Although the complete lack of PMCA2 expression will 
certainly reduce apical Ca2+ transport, this also may be associated with altered homeostatic pathways of
the entire animal manifested as a reduction in the Ca2+ content of milk, or the complete lack of PMCA2 
may be associated with altered function, signaling and/or transcription in mammary gland secretory cells. 
Indeed SPCA1 and SERCA2 levels are increased in PMCA2 null mice (19). SPCA1-null mice have only 
been characterized recently and are embryonic lethal (15). SPCA2-null mice have not been characterized;
however, we would predict from our studies that their phenotype may be associated with altered calcium 
secretion into milk, and an altered lactose content and glycoprotein profile of milk.
Despite our increasing knowledge of the transport of Ca2+ during lactation, important questions still 
remain. Our studies have, however, helped to clarify and highlight the importance of the secretory 
pathway ATPase, SPCA2, during pregnancy and lactation. They have also focused attention on the 
specific roles of the PMCA isoforms, PMCA1 and PMCA2 suggested by their different cellular and sub-
cellular localization in the lactating mouse mammary gland. Given that lactose and the Ca2+ content of 
milk varies among species (13), it will be interesting to see if future studies show species differences in 
the degree of SPCA2 up-regulation during lactation. Since hypocalcaemia (milk fever) during lactation is 
associated with elevated SPCA1 expression in mammary gland biopsies from cows prior to parturition 
(16), assessment of SPCA2 in milk fever also appears warranted. 
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Figure Legends
FIGURE 1: SPCA2 mRNA levels increase more than SPCA1 during murine mammary gland 
development. SPCA2 and SPCA1 mRNA levels during murine mammary gland development (relative to 
nulliparous). Bars represent the mean ± SEM (n = 3-4 mice) and are representative of 2 independent real 
time RT-PCRs. The asterisk (*) denotes a significant difference (P < 0.05) compared to nulliparous 
tissue, using a z-test based on a normal distribution.
FIGURE 2: Immunolocalization of SPCA1 and SPCA2 in the lactating mouse mammary gland.
Mammary gland sections isolated from lactating mice and immunostained for either SPCA2 or SPCA1 
and SMA. A. Localisation of SPCA2. B. The same field of view as in A. showing SPCA2 (green) and 
SMA (red) overlaid with the DAPI (blue) stain. White arrows show cells which do not express SPCA2 
outside the acini. C. Localisation of SPCA1. D. The same field of view as in C. showing SPCA1 (green) 
and SMA (red) overlaid with the DAPI (blue) stain. White arrows show cells not part of secretory acini 
that express SPCA1. Each panel contains a magnified view from the corresponding boxed area. The scale 
bars represent 10 µm in all panels.
FIGURE 3: Immunolocalization of PMCA1 and PMCA2 in the lactating mouse mammary gland.
Mammary gland sections isolated from lactating mice and immunostained for either PMCA1 or PMCA2 
and SMA. In all panels the insert represents a magnified subsection of the acini. A. Localisation of 
PMCA2. B. The same field of view as in A. showing PMCA2 (green) and SMA (red) overlaid with the 
DAPI (blue) staining pattern. C. Localisation of PMCA1. D. The same field of view as in C. showing 
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PMCA1 (green) and SMA (red) overlaid with the DAPI (blue) stain. Each panel contains a magnified 
view from the corresponding boxed area. The scale bars represent 10 µm in all panels.
FIGURE 4: SCp2 cells functionally differentiate, produce milk protein, and express SPCA2. A. 
SCp2 cells grown in a 2D culture. B. SCp2 cells grown in a 3D culture. C. A representative immunoblot 
for -casein in SCp2 cells grown in 2D and treated with normal media (lane 1) or differentiation media 
(lane 2). D. SPCA2 localization in SCp2 cells grown in a 2D culture. E. SPCA2 localization in SCp2 cells 
grown in a 3D culture. The scale bars represent 10 µm in all panels.
FIGURE 5: Localisation of PMCA1 in SCp2 cells grown in 3D culture. A. A representative acinus 
showing staining for DAPI (left), PMCA1 (middle) and 6 integrin (right). B. The merged image of same 
acinus seen in A.; DAPI (blue), PMCA1 (green), 6 integrin (red). C. A montage of the stacks collected 
from the acinus described above. The plane shown in A. and B. corresponds to the image with an asterisk
(*). D. The corresponding z-x plane through the acinus described above. The scale bars represent 10 µm
in all panels. 
FIGURE 6: Localisation of PMCA2 in SCp2 cells grown in 3D culture. A. A representative acinus
showing staining for DAPI (left), PMCA2 (middle) and 6 integrin (right). B. The merged image of same 
acinus seen in A.; DAPI (blue), PMCA2 (green), 6 integrin (red). C. A montage of the stacks collected 
from the acinus described above. The plane shown in A. and B. corresponds to the image with an asterisk
(*). D. The corresponding z-x plane through the acinus described above. The scale bars represent 10 µm
in all panels.
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